Blume Capital Management, Inc. Wave Life Sciences Ltd. Transaction History
Blume Capital Management, Inc.
- $401 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding WVE
# of Institutions
132Shares Held
71.8MCall Options Held
86.1KPut Options Held
20.1K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.69MShares$40.9 Million0.94% of portfolio
-
M28 Capital Management LP Stamford, CT7MShares$37.2 Million40.53% of portfolio
-
Black Rock Inc. New York, NY6.38MShares$33.9 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY5.35MShares$28.5 Million2.81% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.2MShares$27.7 Million0.06% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $462M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...